We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
Cap. Flow
-$469M
Cap. Flow %
-3.86%
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$38.7M
2
AAPL icon
Apple
AAPL
+$27.7M
3
CRM icon
Salesforce
CRM
+$26.1M
4
VZ icon
Verizon
VZ
+$25.9M
5
PEP icon
PepsiCo
PEP
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Technology 24.24%
3 Financials 8.36%
4 Communication Services 6.82%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
426
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2.78M 0.02%
217,187
RJF icon
427
Raymond James Financial
RJF
$33.3B
$2.71M 0.02%
+30,350
New +$2.97M
RLMD icon
428
Relmada Therapeutics
RLMD
$546M
$2.7M 0.02%
142,186
+6,510
+5% +$142K
TWST icon
429
Twist Bioscience
TWST
$5.39B
$2.69M 0.02%
76,841
TWLO icon
430
Twilio
TWLO
$29.5B
$2.68M 0.02%
31,985
-8,800
-22% -$984K
NVR icon
431
NVR
NVR
$16.9B
$2.68M 0.02%
669
+142
+27% +$605K
MLM icon
432
Martin Marietta Materials
MLM
$34.3B
$2.67M 0.02%
8,915
-1,388
-13% -$473K
TRQ
433
DELISTED
Turquoise Hill Resources Ltd
TRQ
$2.66M 0.02%
99,404
CTVA icon
434
Corteva
CTVA
$58.6B
$2.64M 0.02%
48,738
+1,743
+4% +$101K
MNDT
435
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.64M 0.02%
120,888
YMAB
436
DELISTED
Y-mAbs Therapeutics
YMAB
$2.61M 0.02%
172,584
NKTR icon
437
Nektar Therapeutics
NKTR
$2.41B
$2.61M 0.02%
45,729
DHI icon
438
D.R. Horton
DHI
$41.3B
$2.6M 0.02%
39,258
+3,668
+10% +$258K
LEN icon
439
Lennar Class A
LEN
$20.5B
$2.57M 0.02%
37,651
+4,477
+13% +$328K
ZEN
440
DELISTED
ZENDESK INC
ZEN
$2.57M 0.02%
34,698
+23,946
+223% +$2.36M
INFY icon
441
Infosys
INFY
$47.4B
$2.56M 0.02%
138,412
-28,792
-17% -$573K
MRVL icon
442
Marvell Technology
MRVL
$170B
$2.55M 0.02%
58,625
+8,226
+16% +$466K
STZ icon
443
Constellation Brands
STZ
$22.2B
$2.55M 0.02%
10,949
+298
+3% +$72.5K
FITB
444
Fifth Third Bancorp
FITB
$51.7B
$2.55M 0.02%
75,831
-45,547
-38% -$1.71M
ORLY icon
445
O'Reilly Automotive
ORLY
$75.1B
$2.54M 0.02%
60,360
+1,755
+3% +$75.5K
UDR icon
446
UDR
UDR
$12.8B
$2.54M 0.02%
55,107
-28,278
-34% -$1.43M
ROP icon
447
Roper Technologies
ROP
$37.1B
$2.53M 0.02%
6,400
-30,805
-83% -$13.4M
MAR icon
448
Marriott International
MAR
$101B
$2.52M 0.02%
18,493
-8,913
-33% -$1.47M
L icon
449
Loews
L
$24.4B
$2.51M 0.02%
42,401
-979
-2% -$61.6K
CTSH icon
450
Cognizant
CTSH
$22.3B
$2.5M 0.02%
37,096
-13,596
-27% -$1.04M

Similar funds

Candriam SCA's Q2 2022 Portfolio in Review

As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.

  • Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
  • Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
  • Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
  • Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
  • Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
  • Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
  • Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.